Details for New Drug Application (NDA): 207920
✉ Email this page to a colleague
The generic ingredient in NEXIUM 24HR is esomeprazole magnesium. There are seventy-four drug master file entries for this compound. One hundred and twelve suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium profile page.
Summary for 207920
Tradename: | NEXIUM 24HR |
Applicant: | Astrazeneca Lp |
Ingredient: | esomeprazole magnesium |
Patents: | 0 |
Pharmacology for NDA: 207920
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Proton Pump Inhibitors |
Suppliers and Packaging for NDA: 207920
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEXIUM 24HR | esomeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 207920 | NDA | Haleon US Holdings LLC | 0573-2451 | 0573-2451-14 | 1 BOTTLE in 1 CARTON (0573-2451-14) / 14 TABLET in 1 BOTTLE |
NEXIUM 24HR | esomeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 207920 | NDA | Haleon US Holdings LLC | 0573-2451 | 0573-2451-42 | 3 BOTTLE in 1 BLISTER PACK (0573-2451-42) / 14 TABLET in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Nov 23, 2015 | TE: | RLD: | Yes |
Expired US Patents for NDA 207920
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca Lp | NEXIUM 24HR | esomeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 207920-001 | Nov 23, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca Lp | NEXIUM 24HR | esomeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 207920-001 | Nov 23, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca Lp | NEXIUM 24HR | esomeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 207920-001 | Nov 23, 2015 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription